மலேசியன் மரபணு நிறுவனம் News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from மலேசியன் மரபணு நிறுவனம். Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In மலேசியன் மரபணு நிறுவனம் Today - Breaking & Trending Today

One year for country to achieve herd immunity against Covid-19, say scientists | Daily Express Online


Published on: Monday, February 08, 2021
By: Bernama
Photo: AP
Kuala Lumpur: The country is expected to need a year to achieve herd immunity for the coronavirus through the National COVID-19 Immunisation Plan, one of the largest vaccination programmes in Malaysia.
Scientist Ts. Dr Ummirul Mukmimin Kahar from the Malaysian Genome Institute, National Institutes of Biotechnology Malaysia (NIBM) said that to achieve herd immunity, 80 per cent of the population needs to be vaccinated with the COVID-19 vaccine.
Malaysia is expected to receive the COVID-19 vaccine from Pfizer-BioNTech by the end of February with frontline staff being among early recipients of the vaccine. ....

Kuala Lumpur , Ummirul Mukmimin Kahar , Astrazeneca Oxford , Ummirul Mukminin , National Immunisation Plan , Sinovac Biotech , National Pharmaceutical Regulatory Agency , Health Ministry , Malaysian Genome Institute , National Institutes Of Biotechnology Malaysia , Research Institute , National Immunisation , National Institutes , Biotechnology Malaysia , Special Committee , Vaccine Supply , குவாலா லம்பூர் , தேசிய நோய்த்தடுப்பு திட்டம் , ஆரோக்கியம் அமைச்சகம் , மலேசியன் மரபணு நிறுவனம் , தேசிய நிறுவனங்கள் ஆஃப் உயிரி தொழில்நுட்பவியல் மலேசியா , ஆராய்ச்சி நிறுவனம் , தேசிய நோய்த்தடுப்பு , தேசிய நிறுவனங்கள் , உயிரி தொழில்நுட்பவியல் மலேசியா , சிறப்பு குழு ,

Takes a year for nation to achieve herd immunity


KUALA LUMPUR – The country is expected to need a year to achieve herd immunity for the coronavirus through the National COVID-19 Immunisation Plan, one of the largest vaccination programmes in Malaysia.
Scientist Ts. Dr Ummirul Mukmimin Kahar from the Malaysian Genome Institute, National Institutes of Biotechnology Malaysia (NIBM) said that to achieve herd immunity, 80 per cent of the population needs to be vaccinated with the COVID-19 vaccine.
Advertisement
Malaysia is expected to receive the COVID-19 vaccine from Pfizer-BioNTech by the end of February with frontline staff being among early recipients of the vaccine.
“After February, the COVID-19 National Immunisation programme will become one of the largest vaccination exercise in Malaysia. The administration of the vaccine will be implemented in three phases and will run until February 2022,” he told Bernama in a special interview via Zoom here, today. ....

Kuala Lumpur , United Kingdom , Sumatera Utara , South Africa , South African , Astrazeneca Oxford , Ummirul Mukminin , Ummirul Mukmimin Kahar , Ariffin Bahar , Sim Kui , Biontech Comirnaty , National Immunisation Plan , Sinovac Biotech , Committee On Covid , Gamaleya Research Institute , Community Safety Division , National Pharmaceutical Regulatory Agency , Health Ministry , Malaysian Genome Institute , Sibu Municipal Council , National Institutes Of Biotechnology Malaysia , National Immunisation , Ministry Of Science , National Institutes , Biotechnology Malaysia , Gamaleya Research ,